4.3 Article

The Immunogenetics of Autoimmune Cholestasis

Journal

CLINICS IN LIVER DISEASE
Volume 20, Issue 1, Pages 15-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2015.08.002

Keywords

Autoimmunity; Autoimmune liver disease; Mucosal immunity; Primary sclerosing cholangitis; Primary biliary cirrhosis

Funding

  1. Stratified Medicine Award from the UK Medical Research Council [MR/L001489/1]
  2. NIHR Biomedical Research Unit
  3. Wellcome Trust Clinical Research Fellowship [099907/Z/12/Z]
  4. Medical Research Council [MR/L001489/1] Funding Source: researchfish
  5. Wellcome Trust [099907/Z/12/Z] Funding Source: Wellcome Trust
  6. MRC [MR/L001489/1] Funding Source: UKRI

Ask authors/readers for more resources

The immune-mediated hepatobiliary diseases, primary binary cirrhosis and primary sclerosing cholangitis are relatively rare, and account for a significant amount of liver transplant activity and liver-related mortality globally. Precise disease mechanisms are yet to be described, although a contributory role of genetic predisposition is firmly established. In addition to links with the major histocompatibility complex, a number of associations outside this region harbor additional loci which underscore the fundamental role of breaks in immune tolerance and mucosal immunogenicity in the pathogenesis of autoimmune biliary disease. We provide an overview of these key discoveries before discussing putative avenues of therapeutic exploitation based on existing findings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available